oup has also
developed a radiotracer that monitors the level of an enzyme called MAO B that
breaks down dopamine. Levels of MAO B increase as we age, contributing to
dopamine deficiency. A drug called L-Deprenyl inhibits MAO B and is used to
treat patients with Parkinson's and Alzheimer's disease. Fowler says that the
PET studies suggest that if we can do things to enhance the activity of dopamine
in the human brain, we may be able to slow down some of the cognitive and motor
declines in aging and might be able to help determine what doses of the drug
would be most beneficial to an individual.
Paper ORGN 4 will be presented by J. S. Fowler from 11:00 a.m. to 12:00 noon,
Sun., March 29, in the Convention Center Ballroom A I, Level 3.
A nonprofit organization with a membership of more than 155,000 chemists and
chemical engineers, the American Chemical Society publishes scientific journals,
convenes major research conferences, and provides educational, science policy
and career programs in chemistry. Its main offices are in Washington, D.C., and
Columbus, Ohio.
'"/>
Contact: Nancy Blount
n_blount@acs.org
202/872-4440
American Chemical Society
30-Mar-1998
Page: 1 2 Related biology news :1.
Seeing the forest for the trees: The future of environmental policy lies in interaction2.
Seeing how plants split water could provide key to our future energy needs3.
Seeing stars after LASIK? Study suggests certain pre-surgery factors may be to blame4.
Seeing one weapon from a food-borne pathogen5.
Seeing Blue-Yellow Color Perception For The First Time6.
The CIA Would Like To Know What Scientists Are Seeing Over The Rainbow7.
Brain has center for detecting sound motion8.
Brains reward circuitry revealed in procrastinating primates9.
Brain serotonin enzyme finding might explain psychiatric disorders10.
Brain development and puberty may be key factors in learning disorders11.
Organization for Human Brain Mapping 2004 Annual Meeting